NIH Sets Up Minority Health Center

When John Ruffin, former head of the National Institutes of Health's Office of Research on Minority Health (ORMH) was sworn in as the director of the new NIH National Center on Minority Health and Health Disparities (NCMHD) on January 9, the ceremony took place against a background of support from unlikely political corners. The problem of health disparities between ethnic, racial, and socioeconomic groups in the United States has been discussed by NIH for several years.1 But the issue ca

Written byMyrna Watanabe
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

When John Ruffin, former head of the National Institutes of Health's Office of Research on Minority Health (ORMH) was sworn in as the director of the new NIH National Center on Minority Health and Health Disparities (NCMHD) on January 9, the ceremony took place against a background of support from unlikely political corners.

The problem of health disparities between ethnic, racial, and socioeconomic groups in the United States has been discussed by NIH for several years.1 But the issue came to a head in early 1999 with the release of the Institute of Medicine report, The Unequal Burden of Cancer,2 which pointed out the preponderance of some types of cancers--and poorer survival rates--in some ethnic minorities. That summer, Rep. Jesse Jackson Jr. (D-Ill.), introduced a bill in Congress for the establishment of a Center for Minority Health at NIH. Gilbert Friedell, director emeritus of the Markey Cancer Center at the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies